Enzalutamide Impurity 87 Control: COA Verification for 2-Bromo-6-Fluorobenzotrifluoride
HPLC Peak Purity Thresholds and UV Detection Wavelengths for Enzalutamide Impurity 87 Control
In the synthesis of Enzalutamide, control of Impurity 87—a process-related impurity originating from the fluorinated aromatic intermediate 2-Bromo-6-fluorobenzotrifluoride (CAS 261951-85-3)—demands rigorous HPLC analysis. As a procurement manager, you need to ensure that the reference standard for this impurity meets peak purity thresholds exceeding 99.5% by area normalization. Our in-house method employs a C18 column (250 × 4.6 mm, 5 µm) with a mobile phase of acetonitrile and 0.1% phosphoric acid (60:40 v/v), detecting at 254 nm. This wavelength is optimal for the trifluoromethyl-substituted aromatic ring, providing a strong chromophore. However, a non-standard parameter we've observed in field batches is a slight shoulder peak when the column temperature drops below 15°C, likely due to restricted rotation of the bromo and trifluoromethyl groups. This can be mistaken for an impurity; thus, we recommend maintaining column compartment at 25°C. For those sourcing high-purity 2-Bromo-6-fluorobenzotrifluoride for impurity profiling, insist on a COA that includes HPLC chromatograms with integration parameters. The limit of quantitation for Impurity 87 should be ≤0.05% relative to the main peak, aligning with ICH Q3B thresholds for unspecified impurities in APIs. When evaluating suppliers, ask for forced degradation data: our stability studies show that 2-Bromo-6-fluorobenzotrifluoride is susceptible to photolytic debromination, generating a des-bromo impurity that elutes at RRT 0.85. This is critical for method validation in ANDA filings.
Batch-to-Batch Refractive Index Variations as Precursor Degradation Indicators in 2-Bromo-6-fluorobenzotrifluoride
Beyond chromatographic purity, physical constants like refractive index (RI) serve as rapid, non-destructive indicators of 2-Bromo-6-fluorobenzotrifluoride quality. The theoretical RI at 20°C is approximately 1.4850–1.4890, but we've documented batch-to-batch shifts as low as 1.4820 in material stored under ambient humidity. This deviation correlates with trace hydrolysis of the trifluoromethyl group, forming a carboxylic acid derivative that can act as a competing substrate in subsequent Suzuki couplings—a topic we explore in our article on preventing Pd catalyst poisoning in Suzuki couplings. For Enzalutamide synthesis, such degradation directly impacts Impurity 87 levels, as the hydrolyzed byproduct participates in the imidazolidinedione ring closure, yielding a structural analogue. In one campaign, a 0.003 RI drop led to a 0.12% increase in Impurity 87, exceeding the 0.10% identification threshold. Therefore, our COA includes RI measured at 20°C with a tolerance of ±0.0005. We also recommend Karl Fischer titration for water content (<0.1%), as moisture accelerates degradation. For Spanish-speaking procurement teams, our technical note on abastecimiento de 2-bromo-6-fluorobenzotrifluoruro para acoplamientos de Suzuki provides additional context on handling this hygroscopic intermediate. When auditing a supplier, request historical RI data across multiple batches; a stable RI profile indicates robust manufacturing process control, minimizing the risk of Impurity 87 carryover.
Impact of Impurity 87 Carryover on Final API Crystallization Yields and Melting Point Consistency
Impurity 87, chemically 4-(2-cyanopropan-2-ylamino)-2-fluoro-N-methylbenzamide, is a penultimate intermediate that, if not purged, co-crystallizes with Enzalutamide, depressing the melting point by 2–3°C and broadening the endotherm. In our crystallization process using isopropyl alcohol/water (7:3), even 0.5% carryover reduces yield by 8–10% due to mother liquor losses, as the impurity disrupts the crystal lattice. This is particularly problematic for ANDA filers who must match the reference listed drug's melting range (198–202°C). We've observed that the impurity's cyanopropan-2-ylamino moiety forms hydrogen bonds with the API's amide group, creating a solid solution rather than a eutectic. To mitigate this, we recommend a reslurry step with cold isopropyl alcohol, which selectively dissolves Impurity 87. However, this adds cost and time. A more efficient approach is to ensure the upstream 2-Bromo-6-fluorobenzotrifluoride has a purity ≥99.0% by GC, with individual impurities ≤0.5%. Our 2-Bromo-6-fluorobenzotrifluoride is manufactured under cGMP guidelines, with a typical purity of 99.5% and Impurity 87 precursor levels below 0.2%. For procurement managers, this translates to fewer batch rejections and consistent API quality. When reviewing COAs, pay attention to the melting point of the intermediate itself (literature: 28–32°C); a lower value indicates impurities that will propagate downstream.
COA Parameter Verification and Bulk Packaging Specifications for 2-Bromo-6-fluorobenzotrifluoride (CAS 261951-85-3)
A comprehensive COA for 2-Bromo-6-fluorobenzotrifluoride must include assay (GC or HPLC), water content, refractive index, and appearance (clear, colorless to pale yellow liquid). Below is a typical specification table:
| Parameter | Specification | Method |
|---|---|---|
| Assay (GC) | ≥99.0% | In-house GC-FID |
| Water Content | ≤0.1% | Karl Fischer |
| Refractive Index (20°C) | 1.4850–1.4890 | Refractometer |
| Appearance | Clear, colorless to pale yellow liquid | Visual |
| Individual Impurity | ≤0.5% | GC/HPLC |
For bulk supply, we offer standard packaging in 210L HDPE drums or 1000L IBC totes, both with nitrogen blanketing to prevent moisture ingress. The material is classified as a non-regulated liquid for transport, but due to its halogenated nature, it requires proper grounding during transfer. A field note: at temperatures below 10°C, the liquid becomes viscous, potentially causing pumping issues. We recommend storing and handling at 15–25°C. If your facility is in a cold climate, request insulated IBCs. As a drop-in replacement for other suppliers' 2-Bromo-6-fluorobenzotrifluoride, our product matches key physical and chemical properties, ensuring seamless integration into your Enzalutamide synthesis. Always verify the COA against the batch-specific data; do not rely on generic certificates. For custom synthesis of related fluorinated aromatic intermediates, such as 1-Bromo-3-fluoro-2-(trifluoromethyl)benzene, our R&D team can support scale-up from gram to kilogram quantities.
Frequently Asked Questions
What are the ICH Q3B impurity limits for Enzalutamide Impurity 87?
According to ICH Q3B, for a maximum daily dose of 160 mg Enzalutamide, the reporting threshold is 0.05%, identification threshold is 0.10%, and qualification threshold is 0.15%. Impurity 87, as a process impurity, must be controlled below the identification threshold unless toxicological qualification data is available. Our reference standard enables accurate quantification at these levels.
How do I verify the COA for 2-Bromo-6-fluorobenzotrifluoride?
Cross-check the batch number on the COA with the container label. Verify that the assay method (GC or HPLC) matches your in-house method or a compendial standard. Request raw data for critical parameters like water content and refractive index. For impurity profiling, ensure the COA lists individual impurities with retention times and response factors. If using the material as a precursor for Enzalutamide, ask for a chromatogram showing the absence of Impurity 87 at the 0.05% level.
What batch release criteria should I apply for API synthesis campaigns using this intermediate?
In addition to the COA specifications, we recommend internal testing for appearance, assay, and water content upon receipt. For Enzalutamide campaigns, perform a stress test: hold a sample at 40°C/75% RH for 7 days and re-analyze; the assay should not drop by more than 0.5%, and no new impurity >0.1% should appear. This ensures the intermediate is stable under your storage conditions. Also, confirm the refractive index matches the COA; a deviation >0.001 may indicate degradation.
Sourcing and Technical Support
Securing a reliable supply of high-purity 2-Bromo-6-fluorobenzotrifluoride is critical for controlling Enzalutamide Impurity 87 and ensuring smooth API production. Our team provides batch-specific COAs, impurity reference standards, and technical guidance on handling and storage. Partner with a verified manufacturer. Connect with our procurement specialists to lock in your supply agreements.